Spaniel Filip, Vohlídka Pavel, Hrdlicka Jan, Kozený Jirí, Novák Tomás, Motlová Lucie, Cermák Jan, Bednarík Josef, Novák Daniel, Höschl Cyril
Prague Psychiatric Center, Ustavní 191 181 03 Prague 8, Czech Republic.
Schizophr Res. 2008 Jan;98(1-3):312-7. doi: 10.1016/j.schres.2007.09.005. Epub 2007 Oct 24.
ITAREPS presents a mobile phone-based telemedicine solution for weekly remote patient monitoring and disease management in schizophrenia and psychotic disorders in general. The programme provides health professionals with home telemonitoring via a PC-to-phone SMS platform that identifies prodromal symptoms of relapse, to enable early intervention and prevent unnecessary hospitalizations. Its web-based interface offers the authorized physician a longitudinal analysis of the dynamics and development of possible prodromes. This work presents preliminary findings from a one-year mirror-design follow-up evaluation of the programme's clinical effectiveness in 45 patients with psychotic illness. There was a statistically significant 60% decrease in the number of hospitalizations during the mean 283.3+/-111.9 days of participation in the ITAREPS, compared to the same time period before the ITAREPS entry (sign test, p<0.004). Variables significantly influencing the number of hospitalizations after the ITAREPS entry (medication compliance along with factors intrinsic to the ITAREPS, i.e. adherence to the programme and involvement of a family member) suggest a critical role of the programme in controlling the number of relapses and subsequent hospitalizations in psychosis.
ITAREPS提供了一种基于手机的远程医疗解决方案,用于对精神分裂症及一般精神障碍患者进行每周一次的远程患者监测和疾病管理。该项目通过一个从电脑到手机的短信平台为医护人员提供家庭远程监测服务,该平台可识别复发的前驱症状,以便进行早期干预并防止不必要的住院治疗。其基于网络的界面为经授权的医生提供了对可能的前驱症状的动态变化和发展情况的纵向分析。这项工作展示了对该项目在45名精神病患者中的临床疗效进行的为期一年的镜像设计随访评估的初步结果。与参加ITAREPS之前的同一时间段相比,在平均283.3±111.9天的参与ITAREPS期间,住院次数有统计学意义地减少了60%(符号检验,p<(0.004))。在参加ITAREPS之后,对住院次数有显著影响的变量(药物依从性以及ITAREPS本身的因素,即对该项目的坚持和家庭成员的参与)表明该项目在控制精神病复发次数和随后的住院治疗方面起着关键作用。